Company intelligence / Profile preview
D. Western Therapeutics Institute
Nagoya, Aichi, Japandwti.co.jp ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
D. Western Therapeutics Institute specializes in the discovery and development of innovative small molecule drugs, particularly protein kinase inhibitors, with a primary focus on ocular diseases such as glaucoma. The company leverages a proprietary compound library and has several candidates at various stages of development targeting unmet medical needs in ophthalmology.
- Therapeutic areas
- Ophthalmology
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
Beyond the preview
Go deeper on D. Western Therapeutics Institute.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on D. Western Therapeutics Institute.